captan has been researched along with chromium in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Harris, MA; Haws, LC; Kirman, CR; McCoy, A; Proctor, DM; Suh, M; Thompson, CM; Wolf, JC | 1 |
| Babic, M; Chappell, GA; Harris, MA; LeBlanc, KJ; Rager, JE; Ring, CL; Thompson, CM; Wolf, J | 1 |
| Bhat, VS; Cohen, SM; Cullen, JM; Gordon, EB; Harris, MA; Proctor, DM; Thompson, CM; Wood, CE | 1 |
1 review(s) available for captan and chromium
| Article | Year |
|---|---|
An adverse outcome pathway for small intestinal tumors in mice involving chronic cytotoxicity and regenerative hyperplasia: a case study with hexavalent chromium, captan, and folpet.
Topics: Adverse Outcome Pathways; Animals; Captan; Chromium; Duodenum; Fungicides, Industrial; Humans; Hyperplasia; Intestinal Neoplasms; Mice; Phthalimides; Risk Assessment | 2020 |
2 other study(ies) available for captan and chromium
| Article | Year |
|---|---|
Comparison of Toxicity and Recovery in the Duodenum of B6C3F1 Mice Following Treatment with Intestinal Carcinogens Captan, Folpet, and Hexavalent Chromium.
Topics: Administration, Oral; Animals; Captan; Carcinogens; Chromium; Dose-Response Relationship, Drug; Duodenum; Female; Intestinal Mucosa; Mice, Inbred Strains; Phthalimides | 2017 |
Comparison of Gene Expression Responses in the Small Intestine of Mice Following Exposure to 3 Carcinogens Using the S1500+ Gene Set Informs a Potential Common Adverse Outcome Pathway.
Topics: Animals; Captan; Carcinogens; Chromium; Gene Expression Profiling; Hypoxia-Inducible Factor 1, alpha Subunit; Intestine, Small; Mice; Phthalimides | 2019 |